BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 28080955)

  • 1. Leukocytoclastic Vasculitis Secondary to Pyridostigmine (Mestinon): Report of a Possible First Case.
    Singh G; Hodgson T; Clarke DE
    Perm J; 2017; 21():15-240. PubMed ID: 28080955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits from sustained-release pyridostigmine bromide in myasthenia gravis: results of a prospective multicenter open-label trial.
    Sieb JP; Köhler W
    Clin Neurol Neurosurg; 2010 Nov; 112(9):781-4. PubMed ID: 20663605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyridostigmine Suicidal Attempt in a Myasthenia Gravis Patient.
    Malabaey MAT; Al-Saud AA; Alaska YA; Almas A; Malik A
    Am J Case Rep; 2019 Sep; 20():1418-1421. PubMed ID: 31554781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful desensitization protocol for pyridostigmine in a 12 year old patient with myasthenia gravis.
    Kaplan F; Topal E
    Turk J Pediatr; 2023; 65(2):326-329. PubMed ID: 37114698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of myasthenia gravis with cholinesterase inhibitors--principles and pharmacologic monitoring].
    Henze T
    Fortschr Neurol Psychiatr; 1996 Mar; 64(3):110-21. PubMed ID: 8900891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Joint pain and hyperalgesia due to pyridostigmine bromide in a patient with myasthenia gravis.
    Rostedt A; Stålberg E
    Neurology; 2004 Mar; 62(5):835-6. PubMed ID: 15007152
    [No Abstract]   [Full Text] [Related]  

  • 7. Coronary vasospasm secondary to hypercholinergic crisis: an iatrogenic cause of acute myocardial infarction in myasthenia gravis.
    Comerci G; Buffon A; Biondi-Zoccai GG; Ramazzotti V; Romagnoli E; Savino M; Rebuzzi AG; Biasucci LM; Loperfido F; Crea F
    Int J Cardiol; 2005 Sep; 103(3):335-7. PubMed ID: 16098399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyridostigmine-induced dystonic blepharospasm in a patient with ocular myasthenia gravis.
    Voon YC; Yahya WN; Hasan S; Ibrahim NM
    Mov Disord; 2010 Jul; 25(9):1299-300. PubMed ID: 20629121
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of pyridostigmine (Mestinon) on human platelet aggregation.
    Leong CF; Aini-Ardena M; Cheong SK; Norris N
    Malays J Pathol; 2009 Jun; 31(1):45-52. PubMed ID: 19694313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celebrating the 70 years of pyridostigmine on therapy of Myasthenia Gravis: historical aspects of the preliminary trials.
    Lorenzoni PJ; Kay CSK; Ducci RD; Fustes OJH; Werneck LC; Scola RH
    Arq Neuropsiquiatr; 2020 Mar; 78(3):179-181. PubMed ID: 32215460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-varicella myasthenia gravis.
    Saha A; Batra P; Vilhekar KY; Chaturvedi P
    Singapore Med J; 2007 Jun; 48(6):e177-80. PubMed ID: 17538742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexistence of Parkinson's disease and myasthenia gravis: a case report.
    Kao KP; Kwan SY; Lin KP; Chang YC
    Clin Neurol Neurosurg; 1993 Jun; 95(2):137-9. PubMed ID: 8344012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyridostigmine-induced microcephaly.
    Polizzi A; Ruggieri M; Vincent A
    Neurology; 2001 Jun; 56(11):1606-7. PubMed ID: 11409415
    [No Abstract]   [Full Text] [Related]  

  • 14. Pyridostigmine-induced microcephaly.
    Al-Shekhlee A; Robin N; Kaminski HJ
    Neurology; 2001 Jun; 56(11):1606-7. PubMed ID: 11402134
    [No Abstract]   [Full Text] [Related]  

  • 15. Anaphylaxis by pyridostigmine.
    Castellano A; Cabrera M; Robledo T; Martinez-Cócera C; Cimarra M; Llamazares AA; Chamorro M
    Allergy; 1998 Nov; 53(11):1108-9. PubMed ID: 9860251
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of myasthenia gravis with pyridostigmine.
    Grogan WA
    Arch Neurol; 1987 Oct; 44(10):995-6. PubMed ID: 3632385
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of use of pyridostigmine and requirement of vecuronium in patients with myasthenia gravis.
    Tripathi M; Kaushik S; Dubey P
    J Postgrad Med; 2003; 49(4):311-4; discussion 314-5. PubMed ID: 14699228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of plasma exchange and pyridostigmine on respiratory muscle strength and breathing pattern in patients with myasthenia gravis.
    Goti P; Spinelli A; Marconi G; Duranti R; Gigliotti F; Pizzi A; Scano G
    Thorax; 1995 Oct; 50(10):1080-6. PubMed ID: 7491557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pro-arrhythmia effect of pyridostigmine. Apropos of a case].
    Leenhardt A; Thomas O; Haouala H; Benaïm R; Maison-Blanche P; Cauchemez B; Haguenau M; Coumel P; Slama R
    Arch Mal Coeur Vaiss; 1992 Dec; 85(12):1853-6. PubMed ID: 1306628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of myasthenia gravis: focus on pyridostigmine.
    Maggi L; Mantegazza R
    Clin Drug Investig; 2011 Oct; 31(10):691-701. PubMed ID: 21815707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.